4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-145545
Principal Accounting Officer acquired 4,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowen Matthew Principal Accounting Officer | 2026-04-06 | Grant or award | +4,300 | 25,904 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bowen Matthew Principal Accounting Officer | 2026-04-06 | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | D: show line 2 in the form |
Loading xslF345X06/ownership.xml…